JAMP SITAGLIPTIN
Identification of Jamp Sitagliptin
| No description |
Google image searchProduct monograph
Active ingredient
sitagliptin (sitagliptin hydrochloride monohydrate), 25 MG
DIN: 02534134
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 02-FEB-2023
ATC:
- A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
- A10B — BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS (ATC, ATC/DDD)
- A10BH — Dipeptidyl peptidase 4 (DPP-4) inhibitors (ATC, ATC/DDD)
- A10BH01 — SITAGLIPTIN (ATC/DDD)
Reference brand drug: Januvia
